Physician profile
Basim Ali
NPI 1467081521
$951.00
in general payments reported to CMS, 2019-2025
10 companies · $403 in 2025
The $403 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $152 · 2024: $396 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $318.93 | 2023-2025 | Linzess, Viberzi, Creon |
| Janssen Biotech, INC. | $152.56 | 2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $105.80 | 2023-2025 | Entyvio, Gattex |
| Merck Sharp & Dohme LLC | $85.41 | 2023-2024 | Dificid |
| Boston Scientific Corporation | $78.17 | 2024-2025 | Overstitch Endoscopic Suturing System, Apollo Esg System, Orise |
| Conmed Corporation | $74.26 | 2023-2024 | Conmed Generators |
| Medtronic, INC. | $56.11 | 2025 | Nexpowder, Pillcam |
| Ipsen Biopharmaceuticals, INC | $38.58 | 2025 | Iqirvo |
| Genzyme Corporation | $23.09 | 2023 | |
| Intercept Pharmaceuticals, INC. | $18.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basim Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.